Recent events
Recent events tied to this brand in public sources.
Back to profile10 entries
2026
Abbott announces planned nutrition business spin-off
Abbott announced plans to spin off its global nutrition business as a separately listed company. The business, which includes Similac, PediaSure, Pedialyte, Glucerna and Ensure, is expected to complete the transaction by the end of 2027.
2022
Parent sues Abbott over alleged infant formula injuries
A parent filed a complaint against Abbott Laboratories alleging that Abbott cow’s-milk-based formula and/or fortifier caused a premature infant to develop NEC and that the products were misleadingly marketed and inadequately warned about potential risks. These are allegations in the complaint, not a court determination.
2022
Abbott expands recall of Similac PM 60/40 formula
Abbott Nutrition expanded its recall to include some lots of Similac PM 60/40 powdered infant formula following another report of a dangerous bacterial infection. The source notes that the company had recalled three other powdered formulas the previous month.
2022
Abbott recalls six lots of Similac Alimentum in Vietnam
Abbott Laboratories GmbH’s Hanoi representative office announced a voluntary recall in Vietnam of six lots of Similac Alimentum Eye-Q powdered infant formula because they potentially contained two kinds of dangerous bacteria. The article reports that 7,050 cartons had entered the market and that the importer notified customers about the recall.
2022
Similac Alimentum infant formula recall in South Africa
Abbott Laboratories-Nutrition issued a voluntary global recall that included Similac Alimentum 400g infant formula in South Africa after testing confirmed Cronobacter and Salmonella in the product. Consumers were urged to stop using affected products and return them for a full refund.
2022
Abbott China initiates a voluntary recall of infant nutrition products
Abbott China initiated a voluntary recall of the Similac HMFortifi specialized medical-use infant nutrition supplement that had been exported to China, following reports involving infants who consumed certain Abbott-produced formula products and an FDA investigation.
2022
Abbott recalls potentially affected powdered infant formulas
Abbott said it was recalling potentially affected products manufactured at its Sturgis, Michigan facility after reports of infant illnesses linked to bacterial contamination. The recall affected certain products with expiration dates of April 1, 2022, or later. Abbott expressed regret for the concern and inconvenience the situation would cause.
2022
Abbott recalls selected powdered infant formulas
Abbott Nutrition voluntarily recalled selected Similac, Alimentum, and EleCare powdered infant formulas manufactured at its Sturgis, Michigan facility after reports of illnesses involving Cronobacter sakazakii and Salmonella.
2022
Abbott announces recall of three infant-formula product lines
Abbott announced a voluntary recall of Similac, Alimentum and EleCare formula produced at its Sturgis, Michigan factory. The article identifies affected product codes and expiration dates.
2020
Abbott launches Similac Pro-Advance in Canada
Abbott launched Similac Pro-Advance infant formula with 2'-FL, described as the first product of its kind in Canada.